Nrf2 protects against ferroptosis, a type of cell death caused by the iron-dependent accumulation of lipid-reactive oxygen species, and HCC cells expressing Nrf2 have been found to be resistant to lenvatinib. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.